CHOLESTERINUM PLEX

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: CHOLESTERINUM PLEX
Generic name: CHOLESTERINUM, CHOLESTERINUM, HEPATINUM, PULMINUM
Manufacturer: Seroyal USA
Product type: HUMAN OTC DRUG
SPL set ID: 56e10d0b-185f-351a-e054-00144ff8d46c
SPL ID: ed11e5b0-cdb2-1f9a-e053-2995a90a0f16
Version: 3
Effective date: 2022-11-09
Source export date: 2026-10-30
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/e1583c3c823c7746dc6fefae78ac97d01bb558f7b0936fc3b7d2e673d3319207/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:33:08

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		CHOLESTERINUM PLEX	openfda.brand_name
generic name		CHOLESTERINUM, CHOLESTERINUM, HEPATINUM, PULMINUM	openfda.generic_name
manufacturer name		Seroyal USA	openfda.manufacturer_name
ndc	package	62106-1207-0	openfda.package_ndc
ndc	product	62106-1207	openfda.product_ndc
ndc11	package	62106120700	derived:openfda.package_ndc
spl id		ed11e5b0-cdb2-1f9a-e053-2995a90a0f16	id
spl set id		56e10d0b-185f-351a-e054-00144ff8d46c	set_id
unii		857C5Q4J3H	openfda.unii
unii		97C5T2UQ7J	openfda.unii
unii		7A99K6361Z	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Stop use and ask a doctor if symptoms persist or worsen. If pregnant or breastfeeding, ask ahealth professional before use. Keep out of reach of children. In case ofoverdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.